Predictive value of the C-reactive protein-triglyceride-glucose index for new-onset heart failure in patients with type 2 diabetes mellitus and hypertension: An ambidirectional cohort study

Background: Type 2 diabetes mellitus (T2DM) and hypertension frequently coexist and substantially increase the risk of heart failure (HF), particularly HF with preserved ejection fraction (HFpEF). Aims: This study evaluated the association of the C-reactive protein–triglyceride-glucose index (CTI) with new-onset HF in patients with T2DM and hypertension. Methods: A total of 1278 patients with T2DM and hypertension were enrolled in this ambidirectional cohort study. Patients with coronary artery disease, pre-existing HF, moderate-to-severe valvular heart disease, or other major structural heart disease were excluded. Participants were stratified into tertiles according to baseline CTI. The primary endpoint was new-onset HF, with HFpEF and HF with reduced ejection fraction (HFrEF) as secondary endpoints. Median follow-up was 8.8 years. Results: During a median follow-up of 8.8 years, the cumulative incidence of new-onset HF differed significantly across CTI tertiles (overall log-rank P = 0.03), with a higher incidence in the highest CTI tertile than in the lowest tertile ( P = 0.01). This association was primarily driven by HFpEF (overall log-rank P = 0.01), whereas no significant association was observed for HFrEF ( P = 0.72). In multivariable Cox regression analyses, high CTI was independently associated with new-onset HF and HFpEF. Sodium–glucose cotransporter 2 inhibitor use was associated with a lower risk of new-onset HF. Restricted cubic spline analysis demonstrated a significant association between CTI and HFpEF risk ( P = 0.02). Conclusions: Higher CTI levels were independently associated with increased risk of new-onset HF, particularly HFpEF, in patients with T2DM and hypertension.

Authors

Institutions

Publication Details

Journal
Kardiologia Polska
Published
2026-11-12
DOI
https://doi.org/10.33963/v.phj.115732
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Predictive value of the C-reactive protein-triglyceride-glucose index for new-onset heart failure in patients with type 2 diabetes mellitus and hypertension: An ambidirectional cohort study

Ping Yin, Kan Chen, Jun Gu, Xiaohan Qiu et al.
Kardiologia Polska
Heart Failure Treatment and Management
article

Predictive value of the C-reactive protein-triglyceride-glucose index for new-onset heart failure in patients with type 2 diabetes mellitus and hypertension: An ambidirectional cohort study

Ping Yin, Kan Chen, Jun Gu, Xiaohan Qiu, Jie Tan, Junfeng Zhang, Huasu Zeng, Jiahan Ke, Meng Wei, Changqian Wang, Jianan Pan, Min Wang
article en

Abstract

Background: Type 2 diabetes mellitus (T2DM) and hypertension frequently coexist and substantially increase the risk of heart failure (HF), particularly HF with preserved ejection fraction (HFpEF). Aims: This study evaluated the association of the C-reactive protein–triglyceride-glucose index (CTI) with new-onset HF in patients with T2DM and hypertension. Methods: A total of 1278 patients with T2DM and hypertension were enrolled in this ambidirectional cohort study. Patients with coronary artery disease, pre-existing HF, moderate-to-severe valvular heart disease, or other major structural heart disease were excluded. Participants were stratified into tertiles according to baseline CTI. The primary endpoint was new-onset HF, with HFpEF and HF with reduced ejection fraction (HFrEF) as secondary endpoints. Median follow-up was 8.8 years. Results: During a median follow-up of 8.8 years, the cumulative incidence of new-onset HF differed significantly across CTI tertiles (overall log-rank P = 0.03), with a higher incidence in the highest CTI tertile than in the lowest tertile ( P = 0.01). This association was primarily driven by HFpEF (overall log-rank P = 0.01), whereas no significant association was observed for HFrEF ( P = 0.72). In multivariable Cox regression analyses, high CTI was independently associated with new-onset HF and HFpEF. Sodium–glucose cotransporter 2 inhibitor use was associated with a lower risk of new-onset HF. Restricted cubic spline analysis demonstrated a significant association between CTI and HFpEF risk ( P = 0.02). Conclusions: Higher CTI levels were independently associated with increased risk of new-onset HF, particularly HFpEF, in patients with T2DM and hypertension.

Kardiologia Polska
Shanghai Jiao Tong University (CN), Shanghai Ninth People's Hospital (CN)
Shanghai Municipal Health Commission, National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality
Good health and well-being
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon